Aqua Bio Technology ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.66	6	4.84	1.86	13.36
Short-Term Investments	-	-	0.18	-	-
Cash & Short-Term Investments	2.66	6	5.02	1.86	13.36
Cash Growth	-55.71%	19.58%	169.61%	-86.06%	146.01%
Accounts Receivable	0.07	3.74	12.11	1.63	0.31
Other Receivables	0.45	2.99	5.51	0.73	0.1
Receivables	0.52	6.73	17.62	2.37	0.41
Inventory	-	5.52	23.88	8.3	8.09
Other Current Assets	0.11	0.97	2.32	0.24	-
Total Current Assets	3.28	19.22	48.84	12.77	21.86
Property, Plant & Equipment	0.04	18.88	17.15	0.27	0.29
Long-Term Investments	126.7	127.45	-	-	-
Goodwill	-	-	123.47	34.69	2.67
Other Intangible Assets	-	9.78	38.16	16.13	5.88
Long-Term Deferred Charges	-	-	2.97	3.35	3.74
Other Long-Term Assets	-	0.07	7.16	0	-
Total Assets	130.02	175.4	237.74	67.2	34.43
Accounts Payable	8.37	39.28	36.03	3.34	2.28
Accrued Expenses	2.53	18.12	10.09	2.83	0.93
Current Portion of Long-Term Debt	108.77	102.7	22.84	15.89	7.12
Current Portion of Leases	-	7.1	5.64	0.34	-
Current Income Taxes Payable	-	-	-	0.01	-
Other Current Liabilities	9.9	26.06	44.92	2.41	1.73
Total Current Liabilities	129.56	193.25	119.51	24.82	12.06
Long-Term Debt	-	47.7	9.34	-	-
Long-Term Leases	-	28.97	14.9	0.67	-
Long-Term Deferred Tax Liabilities	-	-	7.37	2.32	-
Other Long-Term Liabilities	0.95	13.25	0.85	37.53	3.67
Total Liabilities	130.51	283.17	151.97	65.34	15.72
Common Stock	16.14	272.13	118.54	51.68	51.56
Additional Paid-In Capital	20.65	-	20.45	-	-
Retained Earnings	-	-	-	-	-32.82
Treasury Stock	-0.65	-0.03	-0.03	-0.03	-0.03
Comprehensive Income & Other	-36.63	-379.87	-53.19	-49.79	-
Shareholders' Equity	-0.49	-107.77	85.78	1.86	18.71
Total Liabilities & Equity	130.02	175.4	237.74	67.2	34.43
Total Debt	108.77	186.47	52.71	16.91	7.12
Net Cash (Debt)	-106.11	-180.46	-47.69	-15.04	6.23
Net Cash Growth	-	-	-	-	37.34%
Net Cash Per Share	-41.92	-132.60	-78.08	-36.29	16.22
Filing Date Shares Outstanding	2.58	2.18	1.1	0.41	0.41
Total Common Shares Outstanding	2.58	2.18	1.1	0.41	0.41
Working Capital	-126.28	-174.03	-70.67	-12.05	9.8
Book Value Per Share	-0.19	-49.51	77.66	4.50	45.38
Tangible Book Value	-0.49	-117.55	-75.85	-48.96	10.16
Tangible Book Value Per Share	-0.19	-54.00	-68.68	-118.47	24.65